Abstract
ObjectivesTo compare the risk of serious adverse events, serious infections and death caused by methotrexate and biological disease-modifying antirheumatic drug (bDMARD) combination therapy versus a bDMARD prescribed as monotherapy in...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have